ClinicalTrials.Veeva

Menu

Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Pneumonia

Treatments

Device: noninvasively Bio-electrical Impedance Analysis (BIA)

Study type

Observational

Funder types

Other

Identifiers

NCT04396522
201900375B0

Details and patient eligibility

About

We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.

Full description

Specific aims:

  1. Can serial body composition data be useful for predicting outcomes of patients with pneumonia? (developing sepsis, organ failure, admission to ICU, length of ICU, survival, length of stay in hospital, prolonged mechanical ventilation,..)
  2. Can serial body composition data be integrated into both immune status alternatives (e.g., white blood cell (WBC) count, segment/monocyte ratio, pulse pressure) in such critical illness and monitoring responses (SOFA score, labs) for severe pneumonia patients?
  3. Can serial body composition data reflect clinical variables in patients with pneumonia, and even altered by nutrition intake? (e.g., compare association between nutrition intake amount and groups stratified by body composition, blood pressure, nutritional intake, ...)

Enrollment

194 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult patients with pneumonia admitted to the thoracic ward or medical intensive care unit of Kaohsiung Chang Gung Memorial Hospital

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

HUA Yeh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems